Notably, both insulin resistance and glycerophospholipid metabolism have been linked to colorectal cancer (CRC) progression, potentially facilitating tumor growth and survival through the PI3K-AKT and mTOR signaling pathways. Here, MTOR is linked to Insulin resistance.